10:43 AM EST - Crescita Therapeutics Inc. : Reported its financial results for the second quarter ended June 30, 2018. Revenue was $2.3 million, versus $4.9 million in Q2-17. Adjusted EBITDA loss of $1.3 million, down $2.1 million versus Q2-17, but an improvement of $0.3 million on a year-to-date basis compared to the prior year's period. Crescita Therapeutics Inc.
shares T.CTX are trading unchanged at $0.64.
